Thursday, July 30, 2020

Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing

Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J

No comments:

Post a Comment

Sources: SoftBank invites more banks to join its $40B loan backing its OpenAI investment, requiring them to commit ~$5B each; SoftBank has already invested $30B (Bloomberg)

Bloomberg : Sources: SoftBank invites more banks to join its $40B loan backing its OpenAI investment, requiring them to commit ~$5B each;...